Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,240,000 | 16,927,000 | 17,940,000 | 14,569,000 | 13,234,000 |
| Marketable Securities | 15,943,000 | 10,977,000 | 12,149,000 | 13,897,000 | 12,683,000 |
| Receivables | 3,396,000 | 3,283,000 | 3,327,000 | 3,465,000 | 3,541,000 |
| Inventories | 884,000 | 898,000 | 814,000 | 816,000 | 859,000 |
| TOTAL | $33,727,000 | $34,024,000 | $35,836,000 | $34,918,000 | $32,728,000 |
| Non-Current Assets | |||||
| PPE Net | 4,249,000 | 4,116,000 | 4,006,000 | 3,791,000 | 3,659,000 |
| Investments And Advances | 3,051,000 | 2,221,000 | 1,423,000 | 2,378,000 | 5,739,000 |
| Intangibles | 19,269,000 | 19,555,000 | 19,855,000 | 20,431,000 | 20,620,000 |
| Other Non-Current Assets | 2,914,000 | 2,921,000 | 2,555,000 | 2,787,000 | 2,609,000 |
| TOTAL | $29,483,000 | $28,813,000 | $27,839,000 | $29,387,000 | $32,627,000 |
| Total Assets | $63,210,000 | $62,837,000 | $63,675,000 | $64,305,000 | $65,355,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,999,000 | 2,498,000 | 2,748,000 | 2,747,000 | 2,998,000 |
| Accounts payable and accrued liabilities | 617,000 | 577,000 | 790,000 | 580,000 | 623,000 |
| Accrued Expenses | 3,585,000 | 3,974,000 | 3,928,000 | 4,456,000 | 4,684,000 |
| TOTAL | $8,961,000 | $9,397,000 | $10,605,000 | $10,116,000 | $10,912,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,661,000 | 24,080,000 | 25,614,000 | 25,164,000 | 26,708,000 |
| Other Non-Current Liabilities | 5,842,000 | 7,276,000 | 5,922,000 | 6,016,000 | 5,999,000 |
| TOTAL | $31,498,000 | $31,349,000 | $31,536,000 | $31,182,000 | $32,709,000 |
| Total Liabilities | $40,459,000 | $40,746,000 | $42,141,000 | $41,298,000 | $43,621,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,266,455 | 1,271,555 | 1,275,511 | 1,293,620 | 1,296,341 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 19,829,000 | 19,326,000 | 19,024,000 | 20,706,000 | 19,825,000 |
| Other shareholders' equity | 237,000 | 270,000 | 227,000 | 182,000 | 64,000 |
| TOTAL | $22,751,000 | $22,091,000 | $21,534,000 | $23,007,000 | $21,734,000 |
| Total Liabilities And Equity | $63,210,000 | $62,837,000 | $63,675,000 | $64,305,000 | $65,355,000 |